Abstract
Assessing the Potential of <i>N</i>-Butyl-<scp>l</scp>-deoxynojirimycin (<scp>l</scp>-NBDNJ) in Models of Cystic Fibrosis as a Promising Antibacterial Agent
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have